This has earlier been shown in a previous study where protein loss was associated with worse survival in NHG 1 tumours (Karlsson et al. 2018), indicating that PTPN2 is not prognostic in high-grade tumours, merely in low-grade tumours. This evidence concerns the gene PTPN2 and neoplasm.